Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
Abati S, Bramati C, Bondi S, Lissoni A, Trimarchi M. Oral cancer and precancer: a narrative review on the relevance of early diagnosis. Int J Environ Res Public Health. 2020;17(24):9160.
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749–68.
Dwivedi R, Mehrotra D, Chandra S, Pandey R. A systematic review of potential immunotherapies targeting PRAME in retinoid resistant oral potentially malignant disorders and oral cancer. Curr Mol Med. 2022;22(8):735–46.
George BP, Chandran R, Abrahamse H. Role of phytochemicals in cancer chemoprevention: insights. Antioxidants (Basel). 2021;10(9):1455.
Xiong P, Wang R, Zhang X, DeLa TE, Leon F, Zhang Q, et al. Design, synthesis, and evaluation of genistein analogues as anti-cancer agents. Anticancer Agents Med Chem. 2015;15(9):1197–203.
Hsiao YC, Chueh FS, Ma YS, Lien JC, Hsia TC, Huang WW, et al. Genistein enhances the effects of L-asparaginase on inducing cell apoptosis in human leukemia cancer HL-60 cells. Environ Toxicol. 2021;36(5):764–72.
Yan H, Jiang J, Du A, Gao J, Zhang D, Song L. Genistein enhances radiosensitivity of human hepatocellular carcinoma cells by inducing G2/M arrest and apoptosis. Radiat Res. 2020;193(3):286–300.
Darzynkiewicz Z, Huang X, Zhao H. Analysis of cellular DNA content by flow cytometry. Curr Protoc Immunol. 2017;119:5.7.1-20.
Nolan JP, Duggan E. Analysis of individual extracellular vesicles by flow cytometry. Methods Mol Biol. 2018;1678:79–92.
Adan A, Alizada G, Kiraz Y, Baran Y, Nalbant A. Flow cytometry: basic principles and applications. Crit Rev Biotechnol. 2017;37(2):163–76.
Periyannan V, Annamalai V, Veerasamy V. Syringic acid modulates molecular marker-involved cell proliferation, survival, apoptosis, inflammation, and angiogenesis in DMBA-induced oral squamous cell carcinoma in Syrian hamsters. J Biochem Mol Toxicol. 2020;34(11):e22574.
Nagini S, Kowshik J. The hamster buccal pouch model of oral carcinogenesis. Methods Mol Biol. 2016;1422:341–50.
Manimaran A, Buddhan R, Manoharan S. Emodin downregulates cell proliferation markers during DMBA induced oral carcinogenesis in golden Syrian hamsters. Afr J Tradit Complement Altern Med. 2017;14(2):83–91.
National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington (DC): National Academies Press (US); 2011.
Yapijakis C, Kalogera S, Papakosta V, Vassiliou S. The hamster model of sequential oral carcinogenesis: an update. In Vivo. 2019;33(6):1751–5.
Banys K, Giebultowicz J, Sobczak M, Wyrebiak R, Bielecki W, Wrzesien R, et al. Effect of genistein supplementation on the progression of neoplasms and the level of the modified nucleosides in rats with mammary cancer. In Vivo. 2021;35(4):2059–72.
Donadini A, Maffei M, Cavallero A, Pentenero M, Malacarne D, Di Nallo E, et al. Oral cancer genesis and progression: DNA near-diploid aneuploidization and endoreduplication by high resolution flow cytometry. Cell Oncol. 2010;32(5–6):373–83.
Warnakulasuriya S, Kerr AR. Oral cancer screening: past, present, and future. J Dent Res. 2021;100(12):1313–20.
Cheng J, Qi J, Li XT, Zhou K, Xu JH, Zhou Y, et al. ATRA and genistein synergistically inhibit the metastatic potential of human lung adenocarcinoma cells. Int J Clin Exp Med. 2015;8(3):4220–7.
Vodnik VV, Mojic M, Stamenovic U, Otonicar M, Ajdzanovic V, Maksimovic-Ivanic D, et al. Development of genistein-loaded gold nanoparticles and their antitumor potential against prostate cancer cell lines. Mater Sci Eng C Mater Biol Appl. 2021;124:112078 Online ahead of print.
Ono M, Takeshima M, Nishi A, Higuchi T, Nakano S. Genistein suppresses v-Src-driven proliferative activity by arresting the cell-cycle at G2/M through increasing p21 level in Src-activated human gallbladder carcinoma cells. Nutr Cancer. 2021;73(8):1471–9.
Chen X, Wu Y, Gu J, Liang P, Shen M, Xi J, et al. Anti-invasive effect and pharmacological mechanism of genistein against colorectal cancer. BioFactors. 2020;46(4):620–8.
Ganai AA, Husain M. Genistein attenuates D-GalN induced liver fibrosis/chronic liver damage in rats by blocking the TGF-β/Smad signaling pathways. ChemBiol Interact. 2017;261:80–5.
Ardito F, Di Gioia G, Pellegrino MR, Muzio LL. Genistein as a potential anticancer agent against head and neck squamous cell carcinoma. Curr Top Med Chem. 2018;18(3):174–81.
Polivkova Z, Langova M, Smerak P, Bartova J, Barta I. Antimutagenic effect of genistein. Czech J Food Sci. 2006;24:119–26.
Ali F, Rahul, Naz F, Jyoti S, Hasan Siddique Y. Protective effect of genistein against N-nitrosodiethylamine (NDEA)-induced hepatotoxicity in Swiss albino rats. J Pharm Anal. 2015;5(1):51–7.
Zhou HR, Shen JZ, Fu HY, Zhang F. Genistein-induced anticancer effects on acute leukemia cells involve the regulation of Wnt signaling pathway through H4K20me1 rather than DNA demethylation. Curr Med Sci. 2021;41(5):869–79.
Bhat SS, Prasad SK, Shivamallu C, Prasad KS, Syed A, Reddy P, et al. Genistein: a potent anti-breast cancer agent. Curr Issues Mol Biol. 2021;43(3):1502–17.
Hussein AM, El-Sheikh SM, Darwish ZE, Hussein KA, Gaafa AI. Effect of genistein and oxaliplatin on cancer stem cells in oral squamous cell carcinoma: an experimental study. Alexandria Dental J. 2018;43(1):117–23.
Yang Y, Zhou ZT, Ge JP. Effect of genistein on DMBA-induced oral carcinogenesis in hamster. Carcinogenesis. 2006;27:578–83.
Dev A, Sardoiwala MN, Kushwaha AC, Karmakar S, Choudhury SR. Genistein nanoformulation promotes selective apoptosis in oral squamous cell carcinoma through repression of 3PK-EZH2 signaling pathway. Phytomedicine. 2021;80:153386 Online ahead of print.
Myoung H, Hong SP, Yun PY, Lee JH, Kim MJ. Anticancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion. Cancer Sci. 2003;94:215–20.
Wilailak S, Rochanawutanon M, Srisupundit S, Aumkhyan A, Pattanapanyasat K. Flow cytometric analysis of DNA ploidy and S-phase fraction of stage IIIB cervical carcinoma. Eur J Gynaecol Oncol. 2004;25:428–30.
Zahran AM, Fakhry H, Hussein KA, Abd El-Salam M, Mohamed MA, Tohamy SM, et al. Flow cytometry analysis of DNA ploidy and S-phase fraction in salivary gland tumors of Egyptian patients. Clin Oncol. 2018;3:1393–8.
Sha GH, Lin SQ. Genistein inhibits proliferation of human endometrial endothelial cell in vitro. Chin Med Sci J. 2008;23(1):49–53.
Suzuki S, Kurosawa N. Endonucleases responsible for DNA repair of helix-distorting DNA lesions in the thermophilic crenarchaeon Sulfolobus acidocaldarius in vivo. Extremophiles. 2019;23(5):613–24.
Malloy KM, Wang J, Clark LH, Fang Z, Sun W, Yin Y, et al. Novasoy and genistein inhibit endometrial cancer cell proliferation through disruption of the AKT/mTOR and MAPK signaling pathways. Am J Transl Res. 2018;10(3):784–95.
van der Laak JA, de Bie LM, de Leeuw H, de Wilde PC, Hanselaar AG. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry. J Clin Pathol. 2002;55:446–51.
Messina S, Bitto A, Aguennouz M, Vita GL, Polito F, Irrera N, et al. The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice. NeuromusculDisord. 2011;21(8):579–89.
Le Donne M, Caruso C, Mancuso A, Costa G, Iemmo R, Pizzimenti G, et al. The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause. Arch Gynecol Obstet. 2011;283(6):1319–23.
El-Deftar MF, El-Gerzawi SM, Abdel-Azim AA, Tohamy SM. Prognostic significance of ploidy and S-phase fraction in primary intraoral squamous cell carcinoma and their corresponding metastatic lymph nodes. J Egy Nat Cancer Inst. 2012;24(1):7–14.
Bremmer JF, Brakenhoff RH, Broeckaert MA, Belien JA, Leemans CR, Bloemena E, et al. Prognostic value of DNA ploidy status in patients with oral leukoplakia. Oral Oncol. 2011;47(10):956–60.
Thomas G, Tr S, George SP, Somanathan T, Sarojam S, Krishnankutti N, et al. Prognostic implications of DNA repair, ploidy and telomerase in the malignant transformation risk assessment of leukoplakia. Asian Pac J Cancer Prev. 2020;21(2):309–16.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
This article is autogenerated using RSS feeds and has not been created or edited by OA JF.
Click here for Source link (https://www.springeropen.com/)